Jan 28, 2015
Envision Pharma Group continues expansion in Asia-Pacific region
Envision Pharma Group, engaged by 18 of the top 20 pharma companies to support their Medical Affairs teams and to provide industry-leading software, is pleased to announce the opening of its new office in Tokyo, Japan. The Tokyo office, which will trade under the ProScribe brand, will house professionals from account management, medical writing, and technology teams. This location will provide a dedicated in-country presence to serve Japanese clients’ cultural and language-specific needs.
This investment in a new office housing talented and experienced professionals further augments Envision Pharma Group’s Asia-Pacific capabilities following its acquisition of ProScribe in 2014. Dr Mark Woolley, who leads Envision’s Asia-Pacific expansion, said “We look forward to welcoming our employees to the new office facility in the coming days and weeks, and plan to further expand our Japanese team over the course of 2015.” The office is located in the Marunouchi Trust Tower, with easy access to the main transport links and close to several existing and potential future clients.
Commenting on the investment, Brian Hepburn, CEO said, “We have recognized the need to offer language-specific services in close proximity to our key clients in Japan and are excited to now offer medical and regulatory writing support within Japan, continuing the quality and reputation that ProScribe has established in the Asia-Pacific region.”
Envision Pharma Group employs over 360 professionals with offices in Europe, North America, and Asia-Pacific.
ProScribe KK is located at:
Level 20 Marunouchi Trust Tower - Main
1-8-3 Marunouchi, Chiyoda-ku,
For further information, please email Alex Torre-Tasso (Group Director, Envision Pharma Group): Alex.Torre-Tasso@EnvisionPharmaGroup.com or Professor Karen Woolley (Division Lead, ProScribe): Karen.Woolley@EnvisionPharmaGroup.com.